Literature DB >> 211087

Vascular permeability changes in the central nervous system of rats with hyperacute experimental allergic encephalomyelitis induced with the aid of a substance from Bordetella pertussis.

R K Bergman, J J Munoz, J L Portis.   

Abstract

Development of hyperacute experimental allergic encephalomyelitis in Lewis rats after intraperitoneal administration of a mixture of guinea pig spinal cord emulsion and pertussigen from Bordetella pertussis was accompanied by an increase in vascular permeability in the central nervous system. The increased permeability was most striking in the spinal cord and seemed to be associated with the ascending development of paralysis. Rats that had completely recovered from paralysis did not have any increased permeability in the central nervous system. Rats which developed paralysis after inoculation with either guinea pig spinal cord emulsion alone or with complete Freund adjuvant had only a small degree, if any, of increased permeability in the vascular system of the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 211087      PMCID: PMC422039          DOI: 10.1128/iai.21.2.627-637.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  A HYPERACUTE FORM OF ALLERGIC ENCEPHALOMYELITIS.

Authors:  S LEVINE; E J WENK
Journal:  Am J Pathol       Date:  1965-07       Impact factor: 4.307

2.  ENCEPHALITOGEN-INDUCED INHIBITION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: PREVENTION, SUPPRESSION AND THERAPY.

Authors:  E C ALVORD; C M SHAW; S HRUBY; M W KIES
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

3.  Enhancement of experimental allergic encephalomyelitis by adrenalectomy.

Authors:  S LEVINE; E J WENK; T N MULDOON; S G COHEN
Journal:  Proc Soc Exp Biol Med       Date:  1962-11

4.  Simple method for enhancing development of acute disseminated encephalomyelitis in mice.

Authors:  J M LEE; P K OLITSKY
Journal:  Proc Soc Exp Biol Med       Date:  1955-06

5.  Cerebral vascular permeability and cellular infiltration in experimental allergic encephalomyelitis.

Authors:  S Leibowitz; L Kennedy
Journal:  Immunology       Date:  1972-05       Impact factor: 7.397

Review 6.  Maintenance of immunologic self-tolerance by nonimmunogenic forms of antigen.

Authors:  R H Swanborg
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

7.  Hyperacute allergic encephalomyelitis. A localized form produced by passive transfer and pertussis vaccine.

Authors:  S Levine; R Sowinski
Journal:  Am J Pathol       Date:  1973-10       Impact factor: 4.307

8.  Experimental allergic encephalomyelitis: role of fibrin deposition in immunopathogenesis of inflammation in rats.

Authors:  P Y Paterson
Journal:  Fed Proc       Date:  1976-11

9.  Suppression of allergic encephalomyelitis in rats by means of antibrain serum.

Authors:  P Y PATERSON; S M HARWIN
Journal:  J Exp Med       Date:  1963-05-01       Impact factor: 14.307

10.  Severe active cutaneous hypersensitivity in the rat produced by Hemophilus pertussis vaccine.

Authors:  D A ROWLEY; J CHUTKOW; C ATTIG
Journal:  J Exp Med       Date:  1959-11-01       Impact factor: 14.307

View more
  12 in total

1.  Kindlin-3 regulates integrin activation and adhesion reinforcement of effector T cells.

Authors:  Federico A Moretti; Markus Moser; Ruth Lyck; Michael Abadier; Raphael Ruppert; Britta Engelhardt; Reinhard Fässler
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-02       Impact factor: 11.205

2.  Localization of toxic encephalopathies near lesions of experimental allergic encephalomyelitis.

Authors:  S Levine; R Sowinski
Journal:  Am J Pathol       Date:  1982-05       Impact factor: 4.307

3.  The effect of fibrinopeptides A and B on experimental allergic encephalomyelitis.

Authors:  R Scherer; J Simon; M Abd-el-Fattah; G Ruhenstroth-Bauer
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

4.  Role of toll-like receptors in multiple sclerosis.

Authors:  Socorro Miranda-Hernandez; Alan G Baxter
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

5.  Isolation of the outer membrane components of Bordetella pertussis which enhance the immunogenicity of Haemophilus influenzae type b capsular polysaccharide polyribosyl ribitol phosphate.

Authors:  N Monji; M R Stebbins; D W McCoy; J S Kuo
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

6.  Genetic analysis of the influence of neuroantigen-complete Freund's adjuvant emulsion structures on the sexual dimorphism and susceptibility to experimental allergic encephalomyelitis.

Authors:  Parley D Fillmore; Matthew Brace; Scott A Troutman; Elizabeth P Blankenhorn; Sean Diehl; Mercedes Rincon; Cory Teuscher
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

7.  Prazosin, an alpha 1-adrenergic receptor antagonist, suppresses experimental autoimmune encephalomyelitis in the Lewis rat.

Authors:  C F Brosnan; E A Goldmuntz; W Cammer; S M Factor; B R Bloom; W T Norton
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

8.  Biological activities of crystalline pertussigen from Bordetella pertussis.

Authors:  J J Munoz; H Arai; R K Bergman; P L Sadowski
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

9.  Experimental allergic orchitis in mice. I. Genetic control of susceptibility and resistance to induction of autoimmune orchitis.

Authors:  C Teuscher; S M Smith; E H Goldberg; G M Shearer; K S Tung
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

10.  Blood-brain barrier disruption in CCL2 transgenic mice during pertussis toxin-induced brain inflammation.

Authors:  Angela E Schellenberg; Richard Buist; Marc R Del Bigio; Henrik Toft-Hansen; Reza Khorooshi; Trevor Owens; James Peeling
Journal:  Fluids Barriers CNS       Date:  2012-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.